Press Release – New York, NY – February 5, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharma in $1.075 Million Registered Direct Offering
New York, NY - February 5, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented 60 Degrees Pharmaceuticals, Inc. (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on developing …
Sichenzia Ross Ference Carmel LLP Represents Benjamin Securities, Inc. and D. Boral Capital LLC in $6 Million Initial Public Offering of Huachen AI Parking Management Technology Holding Co., Ltd
New York, NY - February 5, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Benjamin Securities, Inc. and D. Boral Capital LLC as the underwriters in the $6 million initial …
Sichenzia Ross Ference Carmel LLP Represents Callan JMB in $5.12 Million Initial Public Offering
New York, NY - February 5, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented Callan JMB Inc. (NASDAQ: CJMB), an integrative logistics company empowering the healthcare industry …
Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $20 Million Underwritten Public Offering
Press Release – New York, NY – January 30, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and …
Sichenzia Ross Ference Carmel LLP Represents A2Z Cust2Mate Solutions Corp. in $30 Million Public Offering and Concurrent Registered Direct Offering
Press Release – New York, NY – January 29, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) (FRA - WKN: A3CSQ), a global leader …
